Published in Cell Host Microbe on May 15, 2008
Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol (2009) 2.79
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med (2011) 2.30
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol (2009) 2.17
Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 2.11
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat Immunol (2010) 1.57
The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
The biliary epithelium presents antigens to and activates natural killer T cells. Hepatology (2015) 1.52
Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol (2013) 1.42
Invariant NKT cells: regulation and function during viral infection. PLoS Pathog (2012) 1.28
Innate-like recognition of microbes by invariant natural killer T cells. Curr Opin Immunol (2009) 1.28
The genetics of complex cholestatic disorders. Gastroenterology (2013) 1.24
Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology (2011) 1.15
Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med (2011) 1.14
Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology (2009) 1.14
Update on primary biliary cirrhosis. Dig Liver Dis (2010) 1.08
Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol (2009) 1.07
Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc Natl Acad Sci U S A (2013) 1.04
Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol (2008) 1.03
A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males. PLoS One (2010) 1.00
Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol (2013) 0.98
The role of invariant natural killer T cells in microbial immunity. J Infect Chemother (2013) 0.98
The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy (2011) 0.95
Natural killer T cells in health and disease. Front Biosci (Schol Ed) (2011) 0.94
The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol (2010) 0.93
CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. J Immunol (2010) 0.93
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol (2009) 0.91
Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol (2014) 0.91
Translational control of NKT cell cytokine production by p38 MAPK. J Immunol (2011) 0.90
Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol (2011) 0.90
Biliary Mucosal Barrier and Microbiome. Viszeralmedizin (2015) 0.89
Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants. Expert Rev Vaccines (2008) 0.86
A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity. Semin Immunol (2009) 0.86
Targeting the diverse immunological functions expressed by hepatic NKT cells. Expert Opin Ther Targets (2011) 0.86
Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice. J Immunol (2009) 0.85
The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology (2008) 0.85
Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response. Virol J (2011) 0.84
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing (2011) 0.84
No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England. Am J Epidemiol (2014) 0.84
Innate immunity drives the initiation of a murine model of primary biliary cirrhosis. PLoS One (2015) 0.84
Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation. Clin Exp Immunol (2012) 0.83
Distinct roles of Cdc42 in thymopoiesis and effector and memory T cell differentiation. PLoS One (2011) 0.83
The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun (2015) 0.83
Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells. Ann N Y Acad Sci (2012) 0.82
Novosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies. PLoS One (2014) 0.82
Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. J Viral Hepat (2013) 0.81
Natural killer T (NKT) cells in autoimmune hepatitis. Curr Opin Immunol (2013) 0.81
Immunologic mapping of glycomes: implications for cancer diagnosis and therapy. Front Biosci (Schol Ed) (2011) 0.81
Impact of microbes on autoimmune diseases. Arch Immunol Ther Exp (Warsz) (2013) 0.80
Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease. Liver Int (2014) 0.80
Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation. Clin Exp Immunol (2012) 0.80
Structure and function of a novel LD-carboxypeptidase a involved in peptidoglycan recycling. J Bacteriol (2013) 0.79
Environmental factors in primary biliary cirrhosis. Semin Liver Dis (2014) 0.78
Invariant natural killer T cells trigger adaptive lymphocytes to churn up bile. Cell Host Microbe (2008) 0.78
Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther (2015) 0.78
Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Int J Mol Sci (2016) 0.77
Genetic susceptibility to autoimmune liver disease. World J Hepatol (2011) 0.77
mTOR Regulation of Lymphoid Cells in Immunity to Pathogens. Front Immunol (2016) 0.77
Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates. BMC Gastroenterol (2012) 0.77
High levels of FCγR3A and PRF1 expression in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Dig Dis Sci (2012) 0.77
Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis. Am J Pathol (2012) 0.76
Activation strategies for invariant natural killer T cells. Immunogenetics (2016) 0.76
Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol (2012) 0.76
Immune-mediated bile duct injury: The case of primary biliary cirrhosis. World J Gastrointest Pathophysiol (2010) 0.76
Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.75
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Impact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids. Org Biomol Chem (2011) 0.75
The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation. Physiol Rep (2017) 0.75
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 6.38
Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (1992) 5.47
Urban aerosols harbor diverse and dynamic bacterial populations. Proc Natl Acad Sci U S A (2006) 4.62
Bacterial endotoxins and host immune responses. Adv Immunol (1979) 4.50
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med (2000) 4.37
Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol (2005) 4.01
The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity (1997) 3.44
Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol (2007) 3.17
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med (1994) 2.53
Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature (1962) 2.38
Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides. J Exp Med (1974) 2.34
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol (2000) 2.09
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med (1988) 1.89
Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol (2001) 1.79
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med (1994) 1.49
Primary biliary cirrhosis: an epidemiological study. Br Med J (1980) 1.48
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol (2005) 1.47
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
Multiparametric analysis of waterline contamination in dental units. Appl Environ Microbiol (1996) 1.46
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol (2001) 1.46
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology (2006) 1.44
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev (1998) 1.43
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol (2005) 1.39
The unique aromatic catabolic genes in sphingomonads degrading polycyclic aromatic hydrocarbons (PAHs). J Gen Appl Microbiol (2003) 1.33
Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol (2004) 1.29
Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm Genome (1998) 1.27
Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol (1998) 1.17
Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol (1991) 1.17
Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun (2005) 1.14
Biodegradation of polycyclic aromatic hydrocarbons by Sphingomonas strains isolated from the terrestrial subsurface. J Ind Microbiol Biotechnol (2001) 1.13
Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol (2007) 1.12
Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. Eur J Biochem (2000) 1.08
Osteomyelitis and secondary septic arthritis caused by Sphingomonas paucimobilis. Infection (2005) 1.08
Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res (2004) 1.07
Septic shock caused by Sphingomonas paucimobilis bacteremia in a patient with hematopoietic stem cell transplantation. Transpl Infect Dis (2007) 1.06
Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc (1998) 1.05
Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut (1995) 1.05
Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol (2004) 1.04
Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology (1998) 1.03
T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology (1995) 0.99
Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int (2003) 0.98
Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology (1993) 0.94
Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models. J Gastroenterol (2007) 0.94
Chemical structure and function of glycosphingolipids of Sphingomonas spp and their distribution among members of the alpha-4 subclass of Proteobacteria. J Ind Microbiol Biotechnol (1999) 0.92
Sphingomonads from marine environments. J Ind Microbiol Biotechnol (1999) 0.92
Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol (2004) 0.88
Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Devel (2005) 0.86
De novo autoimmune hepatitis after liver transplantation. J Hepatol (2004) 0.83
Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit. Mayo Clin Proc (2006) 0.82
Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces. Lab Invest (1994) 0.81
The epidemiology of primary biliary cirrhosis: immunological problems. Hepatogastroenterology (2000) 0.80
Acute, serious drug-induced liver injury. J Hepatol (2002) 0.80
Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin Proc (1998) 0.80
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet (2007) 19.04
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
The biology of NKT cells. Annu Rev Immunol (2007) 14.43
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 7.72
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Lysosomal glycosphingolipid recognition by NKT cells. Science (2004) 7.31
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet (2007) 6.11
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet (2007) 5.68
Primary biliary cirrhosis. Hepatology (2009) 5.35
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet (2007) 5.09
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
A thymic precursor to the NK T cell lineage. Science (2002) 4.66
Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med (2007) 4.47
Averting biodiversity collapse in tropical forest protected areas. Nature (2012) 4.46
Forest elephant crisis in the Congo Basin. PLoS Biol (2007) 3.74
Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med (2002) 3.70
Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet (2009) 3.59
Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum (2002) 3.30
T1DBase: integration and presentation of complex data for type 1 diabetes research. Nucleic Acids Res (2006) 3.25
Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med (2008) 3.19
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res Cogn Brain Res (2003) 3.14
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol (2005) 3.12
Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity (2004) 3.06
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science (2003) 3.05
Investigation of the cause of death in a gene-therapy trial. N Engl J Med (2009) 3.02
Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity (2007) 3.02
Characterization of the early stages of thymic NKT cell development. J Exp Med (2005) 2.84
Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol (2005) 2.75
Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity (2005) 2.72
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol (2009) 2.66
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Conservation. Elephants, ivory, and trade. Science (2010) 2.51
SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. Immunity (2010) 2.47
Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol (2007) 2.45
A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol Methods (2006) 2.36
Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A (2006) 2.34
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet (2009) 2.30
Surface area congruence of atlas superior articulating facets and occipital condyles. J Chiropr Med (2008) 2.29
Devastating decline of forest elephants in central Africa. PLoS One (2013) 2.28
Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett (2002) 2.21
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol (2003) 2.20
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology (2005) 2.17
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A (2009) 2.13
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2011) 2.12
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. J Am Chem Soc (2004) 2.05
Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol (2001) 2.04
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS (2007) 2.03
The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science (2010) 2.02
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity (2004) 2.00
Gastric mucosal necrosis with vascular degeneration induced by doxycycline. Am J Surg Pathol (2013) 1.99
The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function. Immunity (2012) 1.98
Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest (2002) 1.98
On-chip single-copy real-time reverse-transcription PCR in isolated picoliter droplets. Anal Chem (2008) 1.96
Testing the 8-syndrome structure of the child behavior checklist in 30 societies. J Clin Child Adolesc Psychol (2007) 1.94
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology (2007) 1.93
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res (2005) 1.90
The influence of carbon dioxide on brain activity and metabolism in conscious humans. J Cereb Blood Flow Metab (2010) 1.88
Depressive symptoms and white matter dysfunction in retired NFL players with concussion history. Neurology (2013) 1.87
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol (2010) 1.81
Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. J Exp Med (2006) 1.80
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J Clin Invest (2003) 1.80
Probiotics and immunity. J Gastroenterol (2009) 1.79